{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T20:28:00Z","timestamp":1785788880624,"version":"3.56.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1097\/01.wnf.0000137862.67131.bf","type":"journal-article","created":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T11:58:43Z","timestamp":1094039923000},"page":"187-191","source":"Crossref","is-referenced-by-count":41,"title":["Coenzyme Q 10 Improves Lactic Acidosis, Strokelike Episodes, and Epilepsy in a Patient With MELAS (Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Strokelike episodes)"],"prefix":"10.1097","volume":"27","author":[{"given":"Angel","family":"Berbel-Garcia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Ramon","family":"Barbera-Farre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas Porta","family":"Etessam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Mart\u00ednez","family":"Salio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Cabello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Gutierrez-Rivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolanda","family":"Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210203","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/ana.410170602","article-title":"Mitochondrial myopathies.","volume":"17","author":"Di Mauro","year":"1985","journal-title":"Ann Neurol"},{"key":"R2-8-20210203","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0022-510X(80)90031-3","article-title":"Myoclonus epilepsy associated with red-ragged fibers (mitochondrial abnormalities): disease or syndrome? Light and electron-microscopic studies of two cases and review of the literature.","volume":"47","author":"Fukuhara","year":"1980","journal-title":"J Neurol Sci"},{"key":"R3-8-20210203","first-page":"488","article-title":"Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes: a distinctive clinical syndrome associated with red-ragged fibers.","volume":"481-","author":"Pavlakis","year":"1984","journal-title":"Ann Neurol"},{"key":"R4-8-20210203","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/0002-9394(77)90735-8","article-title":"Mitochondrial abnormalities in progressive external ophthalmoplegia.","volume":"83","author":"Hyman","year":"1977","journal-title":"Am J Ophthalmol"},{"key":"R5-8-20210203","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1212\/WNL.59.8.1275","article-title":"Ubiquinone and nicotinamide treatment of patients with the 3243A-G mtDNA mutation.","volume":"59","author":"Remes","year":"2002","journal-title":"Neurology"},{"key":"R6-8-20210203","first-page":"741","article-title":"Q10 improves mitochondrial respiration in patients with mitochondrial cytopathies: an in vivo study on brain and skeletal muscle by phosphorous magnetic resonance spectroscopy.","volume":"43","author":"Barbiroli","year":"1997","journal-title":"Cell Mol Biol(Noisy-le-grand)"},{"key":"R7-8-20210203","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1080\/000486700286","article-title":"Coenzyme Q10 improves psychiatric symptoms in adult-onset mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes: a case report.","volume":"34","author":"Shinkai","year":"2000","journal-title":"Aust N Z J Psychiatry"},{"key":"R8-8-20210203","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0022-510X(98)00296-2","article-title":"Effect of coenzyme Q10 in patients with mitochondrial, myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): evaluation by noninvasive tissue oximetry.","volume":"162","author":"Abe","year":"1999","journal-title":"J Neurol Sci"},{"key":"R9-8-20210203","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/BF00314013","article-title":"Clinical improvement after administration of coenzyme Q10 in a patient with mitochondrial encephalomyopathy.","volume":"234","author":"Goda","year":"1987","journal-title":"J Neurol"},{"key":"R10-8-20210203","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000117445","article-title":"Coenzyme Q10 treatment in mitochondrial encephalomyopathy: short-term, double-blind, crossover study.","volume":"37","author":"Chen","year":"1997","journal-title":"Eur Neurol"},{"key":"R11-8-20210203","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1600-0404.1991.tb03962.x","article-title":"Marked reduction in CSF lactate and pyruvate levels after CoQ therapy in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS).","volume":"83","author":"Abe","year":"1991","journal-title":"Acta Neurol Scand"},{"key":"R12-8-20210203","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1136\/jnnp.50.11.1475","article-title":"Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes with recurrent abdominal symptoms and coenzyme Q10 administration.","volume":"50","author":"Yamamoto","year":"1987","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R13-8-20210203","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1159\/000310536","article-title":"Improvement of Kearns-Sayre syndrome with controlled carbohydrate intake and coenzyme Q10 therapy.","volume":"208","author":"Berio","year":"1994","journal-title":"Ophthalmologica"},{"key":"R14-8-20210203","first-page":"266","article-title":"Treatment with ubiquinone in Kearns-Sayre syndrome: improvement in ocular motility and visual evoked potentials.","volume":"7","author":"Calatayud","year":"1992","journal-title":"Neurologia"},{"key":"R15-8-20210203","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0022-510X(89)90112-3","article-title":"Mitochondrial encephalomyopathy (MELAS): pathological study and successful therapy with coenzyme Q10 and idebenone.","volume":"90","author":"Ihara","year":"1989","journal-title":"J Neurol Sci"},{"key":"R16-8-20210203","first-page":"842","article-title":"Kearns-Sayre syndrome: mitochondrial encephalomyopathy caused by deficiency of the respiratory chain.","volume":"145","author":"Desnuelle","year":"1989","journal-title":"Rev Neurol (Paris)"},{"key":"R17-8-20210203","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1212\/WNL.38.6.892","article-title":"Clinical and biochemical correlations in mitochondrial myopathy treated with coenzyme Q10.","volume":"38","author":"Bresolin","year":"1988","journal-title":"Neurology"},{"key":"R18-8-20210203","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1212\/WNL.36.1.45","article-title":"Treatment of Kearns-Sayre syndrome with coenzyme Q10.","volume":"36","author":"Ogasahara","year":"1986","journal-title":"Neurology"},{"key":"R19-8-20210203","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1212\/WNL.35.3.372","article-title":"Improvement of abnormal pyruvate metabolism and cardiac conduction defect with coenzyme Q10 in Kearns-Sayre syndrome.","volume":"35","author":"Ogasahara","year":"1985","journal-title":"Neurology"},{"key":"R20-8-20210203","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1212\/WNL.39.3.399","article-title":"Long-term coenzyme Q10 therapy for a mitochondrial encephalomyopathy with cytochrome c oxidase deficiency: a 3D NMR study.","volume":"39","author":"Nishikawa","year":"1989","journal-title":"Neurology"},{"key":"R21-8-20210203","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/ana.10371","article-title":"Coenzyme Q-responsive Leighs encephalopathy in two sisters.","volume":"52","author":"Maldergem","year":"2002","journal-title":"Ann Neurol"},{"key":"R22-8-20210203","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s004150050267","article-title":"Metabolic changes in patients with mitochondrial myopathies and effects of coenzyme Q-10 Therapy.","volume":"245","author":"Chan","year":"1998","journal-title":"J Neurol"},{"key":"R23-8-20210203","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1212\/WNL.43.5.884","article-title":"Coenzyme Q10 with multiple vitamins is generally ineffective in treatment of mitochondrial disease.","volume":"43","author":"Matthews","year":"1993","journal-title":"Neurology"},{"key":"R24-8-20210203","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0022-510X(90)90015-F","article-title":"Ubidecarenone in the treatment of mitochondrial myopathies: a multi-center double-blind trial.","volume":"100","author":"Bresolin","year":"1990","journal-title":"J Neurol Sci"},{"key":"R25-8-20210203","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0022-510X(90)90075-X","article-title":"Exogenous coenzyme Q fails to increase CoQ in skeletal muscle of two patients with mitochondrial cytopathies.","volume":"95","author":"Zierz","year":"1990","journal-title":"J Neurol Sci"},{"key":"R26-8-20210203","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S0960-8966(03)00039-7","article-title":"Two pathogenic mutations in the mitochondrial DNA tRNA Leu (UUR) gene (T3258C and A3280G) resulting in variable clinical phenotypes.","volume":"13","author":"Campos","year":"2003","journal-title":"Neuromuscul Disord"},{"key":"R27-8-20210203","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1096-7192(02)00145-2","article-title":"Coenzyme Q10 and idebenone in the therapy of respiratory chain diseases: rationale and comparative benefits.","volume":"77","author":"Geromel","year":"2002","journal-title":"Mol Genet Metab"},{"key":"R28-8-20210203","first-page":"263","article-title":"Mitochondrial myopathies.","volume":"31","author":"Castro-Gago","year":"2000","journal-title":"Rev Neurol"}],"container-title":["Clinical Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.wnf.0000137862.67131.bf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T19:35:14Z","timestamp":1785785714000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002826-200407000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004]]}},"URL":"https:\/\/doi.org\/10.1097\/01.wnf.0000137862.67131.bf","relation":{},"ISSN":["0362-5664"],"issn-type":[{"value":"0362-5664","type":"print"}],"subject":[],"published":{"date-parts":[[2004,7]]}}}